Clinical Features of the Course of Musculoskeletal Infection after Local Administration of Glucocorticoids
ARTICLE PDF (Українська)

Keywords

glucocorticosteroids
septic arthritis
corticosteroid injections

How to Cite

Hrytsai, M., Tsokalo, V., Kolov, H., & Sabadosh, V. (2022). Clinical Features of the Course of Musculoskeletal Infection after Local Administration of Glucocorticoids. Herald of Orthopaedics, Traumatology and Prosthetics, (1(112), 38-45. https://doi.org/10.37647/0132-2486-2022-112-1-38-45

Abstract

Summary. In the treatment of patients with inflammatory and degenerative-dystrophic lesions of the joints, soft tissues and ligaments, local administration of drugs is often used in practice, usually (mainly) glucocorticoids.

Objective: to determine the place and role of local administration of glucocorticoids in the occurrence and development of musculoskeletal infection.

Materials and Methods. The peculiarities of the occurrence and development of infectious complications, their clinical manifestations, laboratory and anamnestic data after local administration of glucocorticoids in 56 patients aged 24 to 78 years were analyzed.

Results. 44 patients had moderate and severe subcompensated comorbidities. Betamethasone was the most commonly used for injections (32 patients, 57.2%). Glucocorticoids were administered intra-articularly to 43 (76.8%) patients: knee joint (37.5%), shoulder (25.0%), ankle (7.1%), hip (3.6%), elbow and 1st metatarsophalangeal (1 case each). In other cases (bursitis, enthesitis, etc.), glucocorticoids were administered paraarticularly. It was a single injection only in 32%; the rest of patients were injected 2 – 20 times. In 96% of cases, monocultures were microbiologically isolated (S.aureus in 52%). At the time of hospitalization, the acute stage of the infectious process was detected in 22 (39.3%) patients, subacute in 16 (28.6%), and chronic active fistula phase in 18 (32.1%). All cases of clinically similar manifestations are systematized into groups of symptom complexes – clinical variants: 1) abscess and/or phlegmon of paraarticular soft tissues, necrotizing fasciitis; 2) septic bursitis; 3) septic arthritis (synovitis); 4) septic destructive arthritis; 5) osteomyelitis.

Conclusions. We found no clinical differences depending on the drugs used. The most important reasons for the development of infectious complications are ignoring the principles of dosing, multiplicity and time intervals of administration, unreasonable repeated use, and the presence of serious subcompensated comorbidities, which should be considered as a relative contraindication and as a risk factor.

https://doi.org/10.37647/0132-2486-2022-112-1-38-45
ARTICLE PDF (Українська)

References

Hollander Jl, Brown Em Jr, Jessar Ra, Brown Cy. Hydrocortisone and cortisone injected into arthritic joints; comparative effects of and use of hydrocortisone as a local antiarthritic agent. J Am Med Assoc. 1951 Dec 22;147(17):1629-35. DOI: 10.1001/jama.1951.03670340019005. PMID: 14880415.

McBride S, Mowbray J, Caughey W, Wong E, Luey C, Siddiqui A, Alexander Z, Playle V, Askelund T, Hopkins C, Quek N, Ross K, Orec R, Mistry D, Coomarasamy C, Holland D. Epidemiology, Management, and Outcomes of Large and Small Native Joint Septic Arthritis in Adults. Clin Infect Dis. 2020 Jan 2;70(2):271-279. DOI: 10.1093/cid/ciz265. PMID: 30941403.

Yasir M, Goyal A, Bansal P, et al. Corticosteroid Adverse Effects. [Updated 2021 Jul 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK531462/.

Boff D, Crijns H, Teixeira MM, Amaral FA, Proost P. Neutrophils: Beneficial and Harmful Cells in Septic Arthritis. Int J Mol Sci. 2018 Feb 5;19(2):468. DOI: 10.3390/ijms19020468. PMID: 29401737; PMCID: PMC5855690.

В.Н. Коваленко, О.Б. Яременко, Н.М. Шуба и др., Принципы применения глюкокортикоидов в лечении ревматических болезней с учетом их эффективности и безопасности Тематичний номер “Кардіологія, Ревматологія, Кардіохірургія” № 1 (56) лютий 2018 р., 24-26. Режим пошуку: https://health-ua.com/article/35767-printcipy-primeneniya-glyukokortikoidov--v-lechenii-revmaticheskih-boleznej.

V.N. Kovalenko, O.B. Yaremenko, N.M. Shuba et al., Principles of the use of glucocorticoids in the treatment of rheumatic diseases, taking into account their effectiveness and safety; Thematic issue “Cardiology, Rheumatology, Cardiac Surgery” № 1 (56) February 2018, 24-26. (In Russian). Search mode: https://health-ua.com/article/35767-printcipy-primeneniya-glyukokortikoidov--v-lechenii-revmaticheskih-boleznej.

Florschutz AV, Fagan RP, Matar WY, Sawyer RG, Berrios-Torres SI. Surgical site infection risk factors and risk stratification. J Am Acad Orthop Surg. 2015 Apr;23 Suppl(Suppl):S8-S11. DOI: 10.5435/JAAOS-D-14-00447. PMID: 25808971; PMCID: PMC6532633.

Brown CR, Samade R, Turnquist E, Mickley J, Lynch D, Larkin KTM, Speeckaert AL. Assessment for Septic Arthritis in Immunocompetent and Immunocompromised Patients: A Single-Institution Study. J Am Acad Orthop Surg. 2022 Jan 1;30(1):27-35. DOI: 10.5435/JAAOS-D-21-00053. PMID: 34271568.

Bell J, Rasmussen L, Kumar A, Heckman MG, Lesser ER, Whalen J, Shi GG, Wilke BK. Septic Arthritis in Immunosuppressed Patients: Do Laboratory Values Help? J Am Acad Orthop Surg Glob Res Rev. 2020 Mar 17;4(3):e20.00007. DOI: 10.5435/JAAOSGlobal-D-20-00007. PMID: 32440635; PMCID: PMC7209792.

Long B, Koyfman A, Gottlieb M. Evaluation and Management of Septic Arthritis and its Mimics in the Emergency Department. West J Emerg Med. 2019 Mar;20(2):331-341. DOI: 10.5811/westjem.2018.10.40974. Epub 2018 Dec 6. PMID: 30881554; PMCID: PMC6404712.

Butler BA, Fitz DW, Lawton CD, Li DD, Balderama ES, Stover MD. Early diagnosis of septic arthritis in immunocompromised patients. J Orthop Sci. 2018 May;23(3):542-545. DOI: 10.1016/j.jos.2018.02.011. Epub 2018 Mar 5. PMID: 29519562.

Ontiveros ST, Minns AB. Accidental Arthrotomy Causing Aseptic Monoarthritis Due to Agave Sap: A Case Report. Clin Pract Cases Emerg Med. 2021 May;5(2):246-248. DOI: 10.5811/cpcem.2021.4.51835. PMID: 34437016; PMCID: PMC8143809.

Carpenter CR, Schuur JD, Everett WW, Pines JM. Evidence-based diagnostics: adult septic arthritis. Acad Emerg Med. 2011 Aug;18(8):781-96. DOI: 10.1111/j.1553-2712.2011.01121.x. Erratum in: Acad Emerg Med. 2011 Sep;18(9):1011. PMID: 21843213; PMCID: PMC3229263.

Ross KM, Mehr JS, Carothers BL, Greeley RD, Benowitz I, Henry D, McHugh LA, DiFedele L, Adler E, Naqvi S, Taylor L, Lifshitz E, Tan C, Montana BE. Bacterial septic arthritis infections associated with intra-articular injection practices for osteoarthritis knee pain-New Jersey, 2017. Infect Control Hosp Epidemiol. 2019 Sep;40(9):1013-1018. DOI: 10.1017/ice.2019.168. Epub 2019 Jul 17. PMID: 31311611; PMCID: PMC7950910.

Shemesh S, Heller S, Salai M, Velkes S. Septic arthritis of the knee following intraarticular injections in elderly patients: report of six patients. Isr Med Assoc J. 2011 Dec;13(12):757-60. PMID: 22332447.

Cain SM, Enfield KB, Giannetta ET, Sifri CD, Lewis JD. Septic arthritis due to oral streptococci following intra-articular injection: A case series. Am J Infect Control. 2018 Nov;46(11):1301-1303. DOI: 10.1016/j.ajic.2018.04.227. Epub 2018 May 24. PMID: 29805059.

Mol MF, Runhaar J, Bos PK, Dorleijn DMJ, Vis M, Gussekloo J, Bindels PJE, Bierma-Zeinstra SMA. Effectiveness of intramuscular gluteal glucocorticoid injection versus intra-articular glucocorticoid injection in knee osteoarthritis: design of a multicenter randomized, 24 weeks comparative parallel-group trial. BMC Musculoskelet Disord. 2020 Apr 11;21(1):225. DOI: 10.1186/s12891-020-03255-9. PMID: 32278346; PMCID: PMC7149870.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.